Related Experiment Video

Updated: Jun 14, 2026

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Published on: February 22, 2020

Dibutyltin activates MAP kinases in human natural killer cells, in vitro

Sabah O Odman-Ghazi1, Abraham Abraha, Erica Taylor Isom

  • 1Department of Biological Sciences, Tennessee State University, Nashville, TN 37209, USA.

Cell Biology and Toxicology
|March 25, 2010
PubMed

Insights

Dibutyltin (DBT) exposure activates specific immune signaling pathways in natural killer (NK) cells. This activation of mitogen-activated protein kinases (MAPKs) may explain how DBT impairs NK cell tumor-fighting ability.

Area of Science:

  • Immunology
  • Environmental Health
  • Cellular Signaling

Background:

  • Dibutyltin (DBT) is an environmental contaminant found in human blood.
  • Previous studies indicate DBT impairs human natural killer (NK) cell anti-tumor function in vitro.
  • Understanding the mechanism of DBT's immunotoxicity is crucial for public health.

Purpose of the Study:

  • To investigate the effects of DBT on key enzymes within the signaling pathway regulating NK cell responsiveness.
  • To elucidate the specific molecular mechanisms underlying DBT-induced NK cell dysfunction.

Main Methods:

  • In vitro exposure of human NK cells to varying concentrations of DBT.
  • Analysis of protein tyrosine kinases (PTKs), mitogen-activated protein kinases (MAPKs), and MAP2Ks.
  • Assessment of enzyme phosphorylation as an indicator of activation.

Main Results:

  • DBT exposure did not affect PTK activity in NK cells.
  • DBT exposure rapidly increased MAPK phosphorylation (activation) within 10 minutes.
  • DBT-induced MAPK activation was linked to the activation of upstream MAP2Ks.

Conclusions:

  • DBT interferes with the MAPK signaling pathway in NK cells.
  • DBT-induced activation of the MAPK pathway is a potential mechanism for decreased NK cell anti-tumor activity.
  • These findings highlight a molecular basis for DBT's immunotoxicity.

More Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...